Skip to main content
Go back to Resources
Randomized, Double-Blind, Placebo-Controlled Trial of Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for the Treatment of Idiopathic Pneumonia Syndrome After Allogeneic Stem Cell Transplantation: BMT CTN Protocol
Authors:
Secondary:
Volume:
Pagination:
URL:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
Randomized Trial of the ForeseeHome Monitoring Device for Early Detection of Neovascular Age-Related Macular Degeneration. The HOme Monitoring of the Eye (HOME) Study Design - HOME Study Report Number 1
Authors:
Secondary:
Volume:
Pagination:
URL:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
Racial/Ethnic Differences in Clinical Trial Enrollment, Refusal Rates, Ineligibility, and Reasons for Decline Among Patients at Sites in The National Cancer Institute's Community Cancer Centers Program
Authors:
Secondary:
Volume:
Pagination:
URL:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
Progress of the Brain Injury and Mechanisms of Action of Hyperbaric Oxygen (HBO2) for Persistent Post-Concussive Symptoms after Mild Traumatic Brain Injury (BIMA) Study
Authors:
Secondary:
Location:
URL:
Go back to Resources
Go back to Resources
Phase II Randomized, Double-Blinded Comparison of a Single High Dose (5×10(8) TCID 50) of Modified Vaccinia Ankara Compared to a Standard Dose (1×10(8) TCID50) in Healthy Vaccinia-Naïve Individuals
Authors:
Secondary:
Volume:
Pagination:
URL:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
Phase I Randomized Clinical Trial of VRC DNA and rAd5 HIV-1 Vaccine Delivery by Intramuscular (i.m.), Subcutaneous (s.c.) and Intradermal (i.d.) Administration (VRC 011)
Authors:
Secondary:
Volume:
Pagination:
URL:
Keywords:
Abstract:
Go back to Resources
Go back to Resources
Peginterferon and Ribavirin for Treatment of Recurrent Hepatitis C Disease in HCV-HIV Coinfected Liver Transplant Recipients
Authors:
Secondary:
Volume:
Pagination:
URL:
Keywords:
Abstract:
Go back to Resources